Institute of Hematology and Transfusiology
Tbilisi, Georgia
Business management consultant in Tbilisi
8 ა Petre Melikishvili St, Tbilisi 0179
About Institute of Hematology and Transfusiology
"BIA is a leading supplier of company profiles, marketing lists, and business field surveys to local and foreign investors."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Octapharma
2
Rhizen Pharmaceuticals SA
2
Antisoma Research
1
Catalyst Biosciences
1
Celgene Corporation
1
Hoffmann-La Roche
1
MEI Pharma, Inc.
1
Clinical Trials at Institute of Hematology and Transfusiology
During the past decade, Institute of Hematology and Transfusiology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.
2007-01-01
2016-04-01
Completed
459
A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
2010-01-01
2011-01-01
Unknown status
20
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
2011-02-15
2017-10-31
Completed
410
Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients
2013-02-01
2019-12-20
Completed
110
Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII
2014-04-01
2018-12-27
Completed
48
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
2017-12-18
2019-04-13
Completed
11
Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
2019-11-28
2020-10-02
Completed
21
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Institute of Hematology and Transfusiology" #1 sponsor was "Octapharma" with 2 trials, followed by "Rhizen Pharmaceuticals SA" with 2 trials
sponsored, "Antisoma Research" with 1 trials sponsored, "Catalyst Biosciences" with 1 trials sponsored and "Celgene Corporation"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Hematology and Transfusiology"
#1 collaborator was "Kyowa Kirin, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Institute of Hematology and Transfusiology
According to Clinical.Site data, the most researched conditions in "Institute of Hematology and Transfusiology" are
"Severe Hemophilia A" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Follicular Lymphoma (FL)" (1 trials), "Hematological Malignancies" (1 trials) and "Hemophilia A With Inhibitor" (1 trials). Many other conditions were trialed in "Institute of Hematology and Transfusiology" in a lesser frequency.
Clinical Trials Intervention Types at Institute of Hematology and Transfusiology
Most popular intervention types in "Institute of Hematology and Transfusiology" are "Drug" (6 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Tenalisib" (2 trials), "Amonafide + cytarabine" (1 trials), "Aspirin" (1 trials), "Bendamustine" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institute of Hematology and Transfusiology
The vast majority of trials in "Institute of Hematology and Transfusiology" are
6 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Institute of Hematology and Transfusiology
Currently, there are NaN active trials in "Institute of Hematology and Transfusiology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Institute of Hematology and Transfusiology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institute of Hematology and Transfusiology, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".